Psychemedics Profit Margin 2010-2024 | PMD

Current and historical gross margin, operating margin and net profit margin for Psychemedics (PMD) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Psychemedics net profit margin as of September 30, 2024 is -14.59%.
Psychemedics Annual Profit Margins
Psychemedics Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.000B $0.022B
Psychemedics Corporation provides testing services for the detection of abused substances through the analysis of hair samples. Their testing methods utilize a patented technology for performing immunoassays on enzymatically dissolved hair samples with confirmation testing by mass spectrometry.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $19.347B 0.00
Quest Diagnostics (DGX) United States $17.088B 17.32
DaVita (DVA) United States $12.452B 16.10
Encompass Health (EHC) United States $9.516B 22.43
Chemed (CHE) United States $7.874B 24.20
Elanco Animal Health (ELAN) United States $5.749B 13.68
RadNet (RDNT) United States $5.382B 119.18
Option Care Health (OPCH) United States $3.899B 18.48
LifeStance Health (LFST) United States $2.789B 0.00
Amedisys (AMED) United States $2.767B 19.69
Addus HomeCare (ADUS) United States $2.383B 27.96
Astrana Health (ASTH) United States $1.896B 25.92
U.S Physical Therapy (USPH) United States $1.378B 36.23
Pennant (PNTG) United States $0.940B 38.03
Aveanna Healthcare Holdings (AVAH) United States $0.885B 0.00
Atai Life Sciences (ATAI) Germany $0.200B 0.00
Bioqual (BIOQ) United States $0.059B 0.00
Daxor (DXR) United States $0.040B 0.00
Ontrak (OTRK) United States $0.006B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.006B 0.00
IMAC Holdings (BACK) United States $0.001B 0.00